About Biobot Analytics
Biobot Analytics is a Healthcare company based in Cambridge (United States) founded in 2017 by Newsha Ghaeli and Mariana Matus. Tools are provided to map microbes and chemicals of interest. Biobot Analytics has raised $42.69 million across 5 funding rounds from investors including HHS, Plum Alley Investments and Thursday Group. The company has 98 employees. Its chief executive, as recorded, is Mariana Matus. Biobot Analytics offers products and services including Respiratory Reports, Wastewater Surveillance System, and Data Insights Platform. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Population Health Management. Its legal entity is Biobot Analytics, Inc. Its competitors include Color, Unite Us and Metabiota; 3 of its 3 listed competitors have raised funding.
Company details
Biobot Analytics was founded in 2017 and is based in Cambridge, United States. In the biotechnology sector, tools are offered for mapping microbes and chemicals tied to human health. Samples are gathered and examined for pathogens and target chemicals through patented bioassays and robotic processes. Resulting data is processed to detect patterns and generate insights, establishing a Human Health Observatory for analysis.
- Total Equity Funding$42.69M (USD)
in 5 rounds
- Latest Funding Round$13.45M (USD), Series A
May 2025
- InvestorsHHS
& 18 more
- Employee Count98
Products & Services of Biobot Analytics
Biobot Analytics offers a comprehensive portfolio of products and services, including Respiratory Reports, Wastewater Surveillance System, and Data Insights Platform.
Provides real-time tracking of respiratory illnesses from wastewater
Monitors disease outbreaks and drug use trends in communities
Offers predictive health data for resource allocation and research
Funding Insights of Biobot Analytics
Biobot Analytics has successfully raised a total of $42.69M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $13.45 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.69M
- Total Rounds 5
- Last Round Series A — $13.45M
- First Round $2.5M
(May 2018)
- Investors Count 19
All 5 funding rounds of Biobot Analytics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $13.45M | Series A | – | Valor Equity Partners | |
| Oct 2021 | $20M | Series A | – | Thursday Ventures | |
| Apr 2020 | $6.74M | Seed | – | Engine | |
| Apr 2020 | $1.48M | Grant | – | – | |
| May 2018 | $2.5M | Seed | – | Ekistic Ventures |
19 investors in total: 17 institutional and 2 angel.
Investors in Biobot Analytics
Biobot Analytics has secured backing from 19 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include HHS, Plum Alley Investments and Thursday Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Thursday Group is engaged in venture capital and private equity investments. | thursday.vc | |||
VC funding and acceleration support are provided to tech startups. | engine.xyz | Cambridge, United States | ||
| amfaminstitute.com | ||||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
Early-stage centric tech-focused VC firm funding companies in the US | ekistic.com | Chicago, United States | ||
Seed and early-stage investments are made across US and India. | refactor.com | Burlingame, United States | ||
Venture capital fund focused on seed-stage investment in multiple sectors | liquid2.vc | San Francisco, United States | ||
Hyperplane is engaged in providing seed capital to startups. | hyperplane.vc | Boston, United States | ||
Capital and counsel are provided to mission-driven founders by Homebrew. | homebrew.co | Burlingame, United States |
Investor details for Biobot Analytics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biobot Analytics
12 people are tracked at Biobot Analytics (6 in leadership, 2 in board & advisors, 4 in team); the tracked headcount is 98.
| Name | Role | Group |
|---|---|---|
Newsha Ghaeli | Co-Founder & President | Leadership |
Mariana Matus | Co-Founder & CEO | Leadership |
Kaitlyn Hess-Jimenez | Senior Director, Lab & R&D | Leadership |
Neil Patrick O'Connor Jr. | Senior Director, Head Of Sales & Business Development | Leadership |
Dan Orsine | Director Enterprise Accounts | Leadership |
Marisa Donnelly | Director Of Epidemiology | Leadership |
Ahmed Hentati | Investor | Board & advisors |
Samuel Stratford | Investor | Board & advisors |
Adam Thomson | Senior Engineering Manager | Team |
Joshua Harrison | Senior Manager, Data Science | Team |
Morgan Powell | Molecular Supervisor | Team |
Camelia Shuja | Assay Product Delivery Manager | Team |
Complete people profiles for Biobot Analytics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biobot Analytics
3 dated milestones of Biobot Analytics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Biobot Analytics is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Series A, of $13.5M.
Competitors of Biobot Analytics
Biobot Analytics has 3 listed competitors in our database, 3 of them funded. They include Color, Unite Us and Metabiota.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| uniteus.com | 2013 | New York, United States | $195.53M | Cloud-based software for patient interoperability and community management is offered. | ||
| metabiota.com | 2008 | United States | $35.05M | 85 | Epidemic outbreaks are predicted and controlled through risk analytics. |
Detailed competitors of Biobot Analytics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biobot Analytics
The website of Biobot Analytics (biobot.io) receives about 8.5K visits a month.
- Monthly visits8.5K
▼ 48.4% vs previous month
Websites whose visitors overlap most with Biobot Analytics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biobotsurgical.com | 100% | 1.6K | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Biobot Analytics (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biobot Analytics
Complete news archive for Biobot Analytics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biobot Analytics
Biobot Analytics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Biobot Analytics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Mariana Matus is the CEO of Biobot Analytics, as recorded in our data. They have also founded this company.
Biobot Analytics is a funded company, having raised a total of $42.69M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on May 2018.
Biobot Analytics has 98 employees.
Biobot Analytics was founded in 2017 and is based in Cambridge, United States. In the biotechnology sector, tools are offered for mapping microbes and chemicals tied to human health. Samples are gathered and examined for pathogens and target chemicals through patented bioassays and robotic processes. Resulting data is processed to detect patterns and generate insights, establishing a Human Health Observatory for analysis.
Biobot Analytics offers Respiratory Reports, Wastewater Surveillance System, and Data Insights Platform.
Biobot Analytics has 19 investors. Key investors include HHS, Plum Alley Investments, Thursday Group, The Engine, and American Family Insurance Institute for Corporate and Social Impact.
Biobot Analytics operates through Biobot Analytics, Inc..